Literature DB >> 19196057

Novel use of a ureteroscopic stone entrapment device to prevent antegrade stone migration during percutaneous nephrolithotomy.

Matthew Wosnitzer1, Keith Xavier, Mantu Gupta.   

Abstract

The Accordion stone management device is a hydrophilic microcatheter-based tool that blocks stone migration. This instrument has been described for use during ureteroscopy to prevent retropulsion of stone fragments. We used this device during percutaneous nephrolithotomy (PCNL) in 30 patients to prevent antegrade migration of stone fragments (group 1), and find that the device is easily inserted and deployed, preventing antegrade stone fragment migration in all but one patient. When compared with 30 patients who were undergoing PCNL without the Accordion device (group 2), our results suggest that the device prevents antegrade stone fragment migration during PCNL, permits targeting larger stones, reduces the use of ureteral stents, and facilitates tubeless procedures. The Accordion device has proven to be a valuable time and morbidity-saving adjunct to PCNL at our institution.

Entities:  

Mesh:

Year:  2009        PMID: 19196057     DOI: 10.1089/end.2008.0372

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  4 in total

1.  Xenx (Xenolith): preliminary considerations of a new "all-in-one" ureteral guidewire and anti-repulsion device.

Authors:  Emanuele Montanari; Fabrizio Longo; Nicola Macchione; Olivier Traxer
Journal:  Urolithiasis       Date:  2014-11-13       Impact factor: 3.436

2.  Stone scattering during percutaneous nephrolithotomy: role of renal anatomical characteristics.

Authors:  Alireza Aminsharifi; Ali Eslahi; Ali Reza Safarpour; Sasan Mehrabi
Journal:  Urolithiasis       Date:  2014-07-16       Impact factor: 3.436

3.  New instrumentation in percutaneous nephrolithotomy.

Authors:  Joseph W Pugh; Benjamin K Canales
Journal:  Indian J Urol       Date:  2010-07

4.  A contemporary lower pole approach for complete staghorn calculi: outcomes and efficacy.

Authors:  Kyle A Blum; Egor Parkhomenko; Julie Thai; Timothy Tran; Mantu Gupta
Journal:  World J Urol       Date:  2018-04-03       Impact factor: 4.226

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.